Skip to main content
Top
Published in: International Urology and Nephrology 2/2012

01-04-2012 | Nephrology – Review

Time to differentiate ‘decreased kidney function’ from ‘kidney disease’: towards improving the definition of chronic kidney disease

Author: Malvinder S. Parmar

Published in: International Urology and Nephrology | Issue 2/2012

Login to get access

Abstract

Chronic kidney disease (CKD) has become an ‘epidemic’ worldwide, since the publication of K/DOQI guidelines in 2002. This classification indeed has raised the profile of CKD worldwide. However, despite limitations of the glomerular filtration rate (GFR) estimating equations, the majority of this epidemic is caused by the large number of persons with stage 3 CKD, with many elderly individuals with ‘low-normal GFR’ being diagnosed with CKD, when, in fact, the majority of those may not have the disease, and a handful of resources being utilized in investigating these relatively ‘low-risk patients’ with ‘decreased eGFR’ without CKD. Recently, concerns have been raised by nephrologists about this classification system, and I strongly feel that it is important to differentiate ‘decreased kidney function’ from ‘kidney disease’, as the GFR estimating equations predict renal function only and nothing else; therefore, I propose some modifications to improve the current classification, so that limited resources and efforts are effectively focused on managing high-risk patients.
Literature
1.
go back to reference Coresh J et al (2005) Chronic kidney disease awareness, prevalence, trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16(1):180–188PubMedCrossRef Coresh J et al (2005) Chronic kidney disease awareness, prevalence, trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16(1):180–188PubMedCrossRef
2.
go back to reference National Kidney Foundation (2002) kidney disease outcomes quality initiative, clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(Suppl 1):S1–S266 National Kidney Foundation (2002) kidney disease outcomes quality initiative, clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(Suppl 1):S1–S266
4.
go back to reference Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8:117PubMedCrossRef Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8:117PubMedCrossRef
5.
go back to reference Imai E, Horio M, Yamagata K, Eseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S (2008) Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertn Res 31(3):433–441CrossRef Imai E, Horio M, Yamagata K, Eseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S (2008) Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertn Res 31(3):433–441CrossRef
6.
go back to reference Chiu YL et al (2008) Outcomes of stage 3–5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract 109(3):c109–c118PubMedCrossRef Chiu YL et al (2008) Outcomes of stage 3–5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract 109(3):c109–c118PubMedCrossRef
7.
go back to reference Rule AD et al (2006) Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc 81(11):1427–1434PubMedCrossRef Rule AD et al (2006) Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc 81(11):1427–1434PubMedCrossRef
8.
go back to reference Delanaye P, Cohen EP (2008) Formula-based estimates of the GFR: equations variable and uncertain. Nephron Clin Pract 110(1):c48–c53 discussion c54PubMedCrossRef Delanaye P, Cohen EP (2008) Formula-based estimates of the GFR: equations variable and uncertain. Nephron Clin Pract 110(1):c48–c53 discussion c54PubMedCrossRef
9.
go back to reference Glassock RJ, Winearls C (2008) An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 23(4):1117–1121PubMedCrossRef Glassock RJ, Winearls C (2008) An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 23(4):1117–1121PubMedCrossRef
10.
go back to reference Bauer C, Melamed ML, Hostetter TH (2008) Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol 19(5):844–846PubMedCrossRef Bauer C, Melamed ML, Hostetter TH (2008) Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol 19(5):844–846PubMedCrossRef
11.
go back to reference Glassock RJ, Winearls C (2008) Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 3(5):1563–1568PubMedCrossRef Glassock RJ, Winearls C (2008) Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 3(5):1563–1568PubMedCrossRef
12.
go back to reference Glassock RJ, Winearls CG (2008) Routine reporting of estimated glomerular filtration rate: not ready for prime time. Nat Clin Pract Nephrol 4(8):422–423PubMedCrossRef Glassock RJ, Winearls CG (2008) Routine reporting of estimated glomerular filtration rate: not ready for prime time. Nat Clin Pract Nephrol 4(8):422–423PubMedCrossRef
13.
go back to reference Poggio ED, Rule AD (2009) A critical evaluation of chronic kidney disease—should isolated reduced estimated glomerular filtration rate be considered a ‘disease’? Nephrol Dial Transplant 24(3):698–700PubMedCrossRef Poggio ED, Rule AD (2009) A critical evaluation of chronic kidney disease—should isolated reduced estimated glomerular filtration rate be considered a ‘disease’? Nephrol Dial Transplant 24(3):698–700PubMedCrossRef
14.
go back to reference Eckardt KU et al (2009) Definition and classification of CKD: the debate should be about patient prognosis—a position statement from KDOQI and KDIGO. Am J Kidney Dis 53(6):915–920PubMedCrossRef Eckardt KU et al (2009) Definition and classification of CKD: the debate should be about patient prognosis—a position statement from KDOQI and KDIGO. Am J Kidney Dis 53(6):915–920PubMedCrossRef
15.
go back to reference Levey AS et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80(1):17–28PubMedCrossRef Levey AS et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80(1):17–28PubMedCrossRef
16.
go back to reference Wetzels JF et al (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72(5):632–637PubMedCrossRef Wetzels JF et al (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72(5):632–637PubMedCrossRef
17.
go back to reference Levey AS et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470PubMed Levey AS et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470PubMed
18.
go back to reference Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69(2):375–382PubMedCrossRef Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69(2):375–382PubMedCrossRef
19.
go back to reference Coresh J et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047PubMedCrossRef Coresh J et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047PubMedCrossRef
20.
go back to reference Ishani A et al (2006) Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 17(5):1444–1452PubMedCrossRef Ishani A et al (2006) Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 17(5):1444–1452PubMedCrossRef
21.
go back to reference Foster MC et al (2007) Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 167(13):1386–1392PubMedCrossRef Foster MC et al (2007) Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 167(13):1386–1392PubMedCrossRef
22.
go back to reference Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160(5):685–693PubMedCrossRef Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160(5):685–693PubMedCrossRef
23.
go back to reference Mann JF et al (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372(9638):547–553PubMedCrossRef Mann JF et al (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372(9638):547–553PubMedCrossRef
24.
go back to reference Shulman NB et al (1989) Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(5 Suppl):180–193 Shulman NB et al (1989) Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(5 Suppl):180–193
25.
go back to reference Go AS et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305PubMedCrossRef Go AS et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305PubMedCrossRef
26.
go back to reference de Jong PE et al (2008) Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol 3(2):616–623PubMedCrossRef de Jong PE et al (2008) Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol 3(2):616–623PubMedCrossRef
27.
go back to reference Brantsma AH et al (2008) Cardiovascular and renal outcome in subjects with K/DOQI stage 1–3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 23(12):3851–3858PubMedCrossRef Brantsma AH et al (2008) Cardiovascular and renal outcome in subjects with K/DOQI stage 1–3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 23(12):3851–3858PubMedCrossRef
28.
go back to reference Tonelli M et al (2006) Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 332(7555):1426PubMedCrossRef Tonelli M et al (2006) Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 332(7555):1426PubMedCrossRef
29.
go back to reference de Jong PE, Gansevoort RT (2008) Fact or fiction of the epidemic of chronic kidney disease—let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant 23(4):1092–1095PubMedCrossRef de Jong PE, Gansevoort RT (2008) Fact or fiction of the epidemic of chronic kidney disease—let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant 23(4):1092–1095PubMedCrossRef
30.
go back to reference Crowe E, Halpin D, Stevens P (2008) Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ 337:a1530PubMedCrossRef Crowe E, Halpin D, Stevens P (2008) Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ 337:a1530PubMedCrossRef
31.
go back to reference Levey AS et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612PubMed Levey AS et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612PubMed
32.
go back to reference Stevens LA et al (2010) Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 56(3):486–495PubMedCrossRef Stevens LA et al (2010) Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 56(3):486–495PubMedCrossRef
33.
go back to reference Peralta CA et al (2011) Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 305(15):1545–1552PubMedCrossRef Peralta CA et al (2011) Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 305(15):1545–1552PubMedCrossRef
Metadata
Title
Time to differentiate ‘decreased kidney function’ from ‘kidney disease’: towards improving the definition of chronic kidney disease
Author
Malvinder S. Parmar
Publication date
01-04-2012
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-0115-7

Other articles of this Issue 2/2012

International Urology and Nephrology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.